abstract |
The present invention also relates to a method for selectively increasing the bioavailability of a pharmaceutical agent, comprising administering to a subject an oral bioavailability enhancer and a composition comprising a pharmaceutical active ingredient and at least one solvent that, when administered parenterally, achieves active blood levels in a method comprising: the therapeutic agent reaches the therapeutic blood level, but the dissolving agent does not reach the active blood level. The present invention also relates to an oral dosage unit form of a single hexane and a polyalkoxylated castor oil. HE |